The Clinical Times
The Front Page of Medicine

Latest medical news · page 38

The latest headlines across every section, pulled from official and open-access sources.

BMJ Open · Jun 8, 2026

Randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) study

Objective People with severe mental illness (SMI) engage in less physical activity (PA) and more sedentary behaviour (SB) than the general population, contributing to poorer physical health outcomes in this population. Therefore, the aim of this study was to evaluate the feasibility of a multi-component behaviour change intervention called Walking fOR Health (WORtH), delivered by community mental health teams, aimed at increasing PA and reducing SB compared with a one-off education session in people with SMI. Design Feasibility randomised controlled trial (RCT). Setting Study recruitment and…

JAMA Network Open · Jun 8, 2026

Restarting Medications After Deprescribing Among Older Adults

This cohort study evaluates medication restart patterns after hospital-initiated deprescribing, identifies factors associated with restart, and examines associations between restart and acute health care utilization.

MedCity News · Jun 7, 2026

Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm?

Healthcare advocates warn that a new CMS rule on Medicaid work requirement exemptions could increase red tape and cause eligible people to lose coverage. The post Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm? appeared first on MedCity News .

ADA (Diabetes) · Jun 7, 2026

ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions

ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions mcarmody Sun, 06/07/2026 - 16:09 Press release ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions NEW ORLEANS, La. June 8, 2026 First Head-to-Head Trial Compares Two Oral GLP-1 RAs Effects on Glucose Control and Weight Changes in Type 2 Diabetes   New data show the benefits of orforglipron…

ADA (Diabetes) · Jun 7, 2026

The American Diabetes Association’s Statement Regarding Nonpartisanship

The American Diabetes Association’s Statement Regarding Nonpartisanship mcarmody Sun, 06/07/2026 - 15:46 Official Statement The American Diabetes Association’s Statement Regarding Nonpartisanship ARLINGTON, Va. June 7, 2026 As many of you are now aware, an incident took place at the American Diabetes Association’s (ADA) Scientific Sessions.  As a 501(c)(3) organization, the ADA has safeguards in place to ensure that it complies with all IRS regulations. This includes maintaining a strictly nonpartisan environment at all organizational events and functions while engaging across party…

ADA (Diabetes) · Jun 7, 2026

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications mcarmody Sun, 06/07/2026 - 15:18 Press release Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications NEW ORLEANS, La. June 7, 2026 Embargoed until Sunday, June 7, 2026, at 4:30 p.m. CT   Findings Demonstrate Potential for Amylin and GLP-1 Combinations as Next Generation of Weight Loss and Diabetes Treatment   New international study findings demonstrated positive results of the first injectable glucagon-like peptide-1…

ADA (Diabetes) · Jun 7, 2026

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes mcarmody Sun, 06/07/2026 - 13:28 Press release Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes NEW ORLEANS, La. June 7, 2026 Once-Monthly Injection Reduced Triglycerides and the Risk of Acute Pancreatitis; Bi-Weekly Injection Lowered “Bad” Cholesterol and Cardiovascular Events   New data presented at the 2026 Scientific Sessions of the American Diabetes Association ® (ADA) demonstrate the benefits of using medications to address…

MedCity News · Jun 7, 2026

It’s Time for Technology to Lift Maternal Care

Improving maternal safety will not come from adding more data or more devices. It will come from building systems that help clinicians recognize risk earlier and communicate and act with confidence in the moment. The post It’s Time for Technology to Lift Maternal Care appeared first on MedCity News .

← NewerOlder →

Back to the live front page